Research Solutions Q2 FY23 revenue up 10.7% to $8.7M; platform rev +31%, ARR $8.8M

Research Solutions, Inc.

2023-Q2 EPS reported $0.00 revenue$17,401,309

Total revenue $8.7M (+10.7% YoY); platform rev $2.1M (+31%); transaction rev $6.6M (+5.4%).
Gross margin +300bps to 39.0%; net loss narrows to ($0.01)/shr from ($0.02)/shr.
Adjusted EBITDA positive at $201K vs -$165K; operating cash flow $0.9M for the quarter.
ARR up 28% to $8.8M; added 34 net platform deployments, ending at 790 deployments.
New Curedatis offering launched in Q2; management confident in long-term platform growth.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Research Solutions, Inc. reported fiscal second quarter ended December 31, 2022 results: revenue $8.7 million, net income ($256,000), or ($0.01) per share, EPS ($0.01) per share.

Period: fiscal second quarter ended December 31, 2022
Revenue: $8.7 million
Net income: ($256,000), or ($0.01) per share
EPS: ($0.01) per share
Result: reported results

Exact text from the filing

solutions for R&D driven organizations, reported financial results for its fiscal second quarter ended December 31, 2022. Fiscal Second Quarter 2023 Summary · Total revenue of $8.7 million, a 10.7% increase from prior-year quarter representing the Company’s second consecutive quarter of double-digit revenue growth · Platform revenue up 31% to $2.1 million. Annual

View on SEC.gov

Browse all earnings releases →

Research Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-017587

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.